Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter, NanoLogix

Premium

The GenomeLab GeXP genetic analysis system was launched this week by Beckman Coulter, the company said in a statement. The system's "patented priming strategy" can overcome biases that limit traditional PCR to a multiplex composed of only a few genes, Beckman said. The system can run in two 96-well plates in 24 hours, with 20 to 35 genes per reaction well, the company said. GenomeLab operates at "a fraction" of the cost of a standard PCR system, Beckman added.

NanoLogix has developed a simpler, faster nucleic-acid extraction buffer called the NanoLogix buffer, the company said in a statement.

Filed under

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.